First, we only reported here information on two representative patients with MG (one with AChR-IgG, and one with MuSk-IgG) before and after receiving CAR-T treatment, and a larger cohort is needed for enhancing the reliability of the results. The gene discussed is MUSK; the disease is myasthenia gravis.